Special Offers & Promotions



Latest News



View Channel

New Products



View Channel

Video Presentations



View Channel

Separation Science



View Channel

Microscopy & Image Analysis



View Channel

Laboratory Automation & IT Solutions



View Channel


Medivir Outsources Compound Management to BioAscent

publication date: Sep 28, 2017
author/source: BioAscent Discovery Limited

Entire library of 56,000 samples transferred in under 3 days

bioascentBioAscent Discovery Limited has taken delivery of Medivir AB’s compound collection of around 56,000 samples, to manage on an outsourced basis.

To ensure business continuity during this transfer process, the complete collection was transferred within three working days, and all compounds were available for delivery to Medivir discovery scientists in less than one week. As well as the existing collection of protease inhibitors and nucleoside analogues, new compounds are being synthesised and delivered to BioAscent each week from Medivir’s CRO partner in India. BioAscent collect and integrate these new compounds into the existing collection and also prepare master stock solutions for Medivir drug discovery activities. Medivir scientists order compounds on a weekly basis and BioAscent supplies them in ready to be tested formats. 

BioAscent’s Newhouse facility offers scalable and highly secure infrastructure, capable of managing solid and liquid compounds, in numerous tube and microplate formats, from ambient to -20 °C. Medivir’s compounds are stored as solids or DMSO solutions in master vials within BioAscent’s automated stores at room temperature or -20 oC. Samples to be tested are prepared as requested, and with a turnaround time of just 2.5 working days from receipt of order to delivery to Medivir in Sweden, service time is as fast as when managed in-house by Medivir. BioAscent is also processing and despatching compounds to Medivir research partners in Europe, the USA and Asia.

To manage the complex requirements of its pharma and biotech clients, BioAscent uses Mosaic sample management software as standard. The company has the flexibility to work with other sample management software as required, and Medivir is able to search and order samples held at BioAscent.

Explaining the quick and smooth transfer, Dr Sylviane Boucharens, BioAscent’s COO/CSO, commented: “The BioAscent team is highly experienced at planning the transfer process in meticulous detail, and the Medivir and BioAscent teams combined well to ensure that there was little or no downtime.”

Mr Paul Smith, CEO, BioAscent, added:  “The number of companies outsourcing the management of their compound libraries to BioAscent continues to grow apace and we are very pleased to be managing Medivir’s expanding library. Our purpose-built facility near Edinburgh, Scotland is designed for both small and large collections, and we expect to have more announcements in the near future. This continued growth and trust in BioAscent’s world–class facility in Scotland is the perfect platform from which to build our new range of complementary drug discovery services.”

more about bioascent




Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month

Top 10 most popular articles this month



Today's Picks



Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners


Exhibitions & Events